MIR MedMira Inc.

TSXV · CA · Healthcare · Biotechnology · medmira.com

0.0600CAD-14.29%Mkt Cap: 30.66M $P/E: —4d ago

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that de…

Industry Peers

Biotechnology

Screen all

VRTX

Vertex Pharmaceuticals Incorporated - Common Stock

$127.85BUSDP/E 29.4

MRNA

Moderna, Inc. - Common Stock

$75.86BUSD

REGN

Regeneron Pharmaceuticals, Inc. - Common Stock

$75.69BUSDP/E 18.2

ARGX

argenx SE - American Depositary Shares

Revolution Medicines, Inc. - Common Stock

BeOne Medicines Ltd. - American Depositary Shares

$40.51BUSDP/E 63.9

RPRX

Royalty Pharma plc - Class A Ordinary Shares

$33.03BUSDP/E 30.7

ALNY

Alnylam Pharmaceuticals, Inc. - Common Stock

$29.40BUSDP/E 38.3

ROIV

Roivant Sciences Ltd. - Common Shares

$25.80BUSD

BNTX

BioNTech SE - American Depositary Shares

$24.34BUSD

INSM

Insmed Incorporated - Common Stock

$24.27BUSD

INCY

Incyte Corporation - Common Stock

$23.37BUSDP/E 14.7

GMAB

Genmab A/S - American Depositary Shares

Jazz Pharmaceuticals plc - Ordinary Shares

$15.30BUSDP/E 16.1

ASND

Ascendis Pharma A/S - Ordinary Share

$14.99BUSDP/E 17.8

EXEL

Exelixis, Inc. - Common Stock

$14.47BUSDP/E 18.4

SMMT

Summit Therapeutics Inc. - Common Stock

$13.37BUSD

Key Statistics

Company

Market Cap30.66M USD

Enterprise Value—

Revenue (TTM)269.87K USD

Gross Profit125.88K USD

Net Income (TTM)-3.29M USD

Revenue/Share0.0010 CAD

Last Price0.0600 CAD

Fiscal Year EndJul 2025

MR QuarterApr 2026

Employees—

CountryCA

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S113.62

P/B-1.71

EPS (TTM)0.00

EPS (Forward)—

52W Range

0.050017% of range0.1100

52W High0.1100 CAD

52W Low0.0500 CAD

Profitability

Gross Margin71.87%

Oper. Margin-109.79%

EBITDA Margin0.00%

Profit Margin-1881.18%

ROE20.05%

ROA-122.89%

Growth

Revenue Growth308.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.29M USD

CapEx (TTM)5.44K USD

FCF Margin-32.13%

FCF Yield-0.28%

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity-0.47

Current Ratio0.06

Quick Ratio0.05

Book Value/Sh-0.04 CAD

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.701.73M

Float209.72M

Insiders65.54%

Institutions0.00%

Short Interest

Short Ratio0.0d

Short % Out.0.00%

Shares Short1.99K

Short (prev mo.)721

Technical

SMA 500.0672 (-10.7%)

SMA 2000.0669 (-10.4%)

Beta0.80

S&P 52W Chg14.58%

Avg Vol (30d)66.35K

Avg Vol (10d)26.14K

Technical Indicators

RSI (14)39.9

MACD-0.0000

MACD Signal0.0006

MACD Hist.-0.0007

BB Upper0.0751 CAD

BB Middle0.0685 CAD

BB Lower0.0619 CAD

BB Width19.18%

ATR (14)0.0041 CAD

Vol Ratio (20d)0.26x